- In February 2025, researchers at the University of Chicago launched a clinical trial evaluating the use of atorvastatin to reduce lesion burden in patients with familial CCM, marking a potential breakthrough in medical therapy for this condition.
- In October 2024, the Angioma Alliance and NIH initiated a global registry for cerebral cavernous malformation patients, aimed at improving data collection, clinical trial readiness, and research collaboration across institutions.
- In August 2024, Medtronic announced the launch of its next-generation neuronavigation system, enhancing the precision of CCM surgical resections and reducing intraoperative complications in neurosurgical centers.
